サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1588574

スポットモニターの世界市場：2024年～2031年

Global Spot Monitor Market - 2024-2031

出版日
ページ情報
英文 183 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
スポットモニターの世界市場：2024年～2031年
出版日: 2024年11月08日
発行: DataM Intelligence
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界のスポットモニター市場は2023年に74億1,000万米ドルに達し、2031年には124億1,000万米ドルに達すると予測され、予測期間2024-2031年のCAGRは6.7%で成長します。

スポットモニターは、バイタルサインの測定値を1回だけ取得し、特定の瞬間の患者の状態を素早く「スナップショット」する医療機器です。この機能は、ヘルスケア専門家が患者の健康を効率的に評価・監視するために不可欠です。

心不全、不整脈、冠動脈疾患、呼吸器疾患、糖尿病、神経疾患を含む心血管疾患（CVD）などの慢性疾患の罹患率の上昇は、スポットモニター市場の重要な促進要因です。例えば、2024年10月のCDCのデータによると、心臓病は米国の男性、女性、ほとんどの人種・民族の人々の死因のトップです。33秒に1人が心血管疾患で死亡しています。2022年には70万2,880人が心臓病で死亡しました。これらすべての要因により、スポットモニター市場が求められています。

市場力学：

促進要因と抑制要因

慢性疾患の有病率の上昇

慢性疾患の有病率の上昇がスポットモニター市場の成長を大きく促進しており、市場予測期間を通じて牽引していくとみられます。

心血管疾患、糖尿病、呼吸器疾患などのライフスタイルに関連した慢性疾患の増加は、バイタルサインの継続的で正確なモニタリングを必要とします。この動向は、より良い疾病管理のためにタイムリーなデータを提供する効果的なスポットモニタリングソリューションの需要を促進します。

2023年9月のWHOのデータによると、NCDは年間4,100万人の死亡の原因となっており、世界の死亡原因の第1位となっています。毎年、約1,700万人が70歳になる前にNCDで死亡しています。NCDによる早期死亡の86%は中低所得国で発生しています。NCDによる死亡の77%はこれらの地域で起こっています。これらすべての要因がスポットモニター市場に要求しています。

さらに、提携や協力などの主要企業の戦略は、心臓リズム管理機器市場の成長を促進すると思われます。例えば、2023年6月、Royal Philipsは、心血管および血管内疾患に特化した著名な医療機器企業であるBIOTRONIKとの提携を発表しました。この提携は、PhilipsのSymphonySuiteの顧客が利用できる心血管デバイスの範囲を拡大し、オフィスベースのラボ（OBL）や外来手術センター（ASC）のような外来患者ケア環境向けの製品を強化することを目的としています。

さらに、高齢化人口の増加と技術の進歩が、予測期間中にスポット市場を牽引すると予想される要因です。

機器の高コスト

高度なスポット・モニタリング・システムに必要な初期投資は、デバイス自体のコストだけでなく、スタッフのトレーニングや既存のヘルスケア・インフラへの統合に関連する追加費用も含めて、かなりの額になる可能性があります。

高度なスポット・モニタリング・デバイスは高価であり、その特徴や機能によっては数千ドルすることもしばしばです。例えば、複数のバイタルサイン測定を提供したり、遠隔医療システムと統合したりする高機能モデルは、価格帯が高くなる可能性があります。

例えば、MindrayのePM 10A Patient Monitorは、ヘルスケア環境向けに設計されたバイタルサインモニター装置です。このモニターの販売価格は4,295米ドル～4,695米ドルです。デバイスの高コストは、スポットモニター市場の成長を妨げると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 慢性疾患の増加
    • 抑制要因
      • デバイスの高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 製品タイプ別

  • スタンドアロンスポットモニター
  • ポータブルスポットモニター
  • ウェアラブルスポットモニター
  • 一体型スポットモニター（他の機器と一体化したモニター）

第7章 モニタリング項目別

  • バイタルサインモニタリング
    • 心拍数
    • 血圧
    • 酸素飽和度（SpO2）
    • 体温
    • 呼吸数
  • 心臓モニタリング
    • 心電図
    • 不整脈検出
  • 神経モニタリング
    • 脳活動
    • 頭蓋内圧モニタリング

第8章 用途別

  • 病院設定
  • 救急部門
  • 集中治療室（ICU）
  • 手術室
  • 外来患者ケア
  • 在宅ヘルスケア
  • スポーツ医学
  • 産業現場

第9章 エンドユーザー別

  • 病院
  • クリニック
  • 在宅ヘルスケアプロバイダー
  • リハビリセンター
  • スポーツ施設

第10章 流通チャネル別

  • 直販
  • 医療機器流通業者
  • オンライン販売

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Koninklijke Philips N.V.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Baxter International Inc.
  • Masimo
  • Medtronic
  • GE HealthCare.
  • Mindray DS USA, Inc.
  • Nihon Kohden Corporation
  • OMRON Healthcare, Inc.
  • ZOLL Medical Corporation
  • Contec

第14章 付録

目次
Product Code: MD8717

Overview

The global spot monitor market reached US$ 7.41 billion in 2023 and is expected to reach US$ 12.41 billion by 2031, growing at a CAGR of 6.7% during the forecast period 2024-2031.

A spot monitor is a medical device that captures a single vital signs measurement, providing a quick "snapshot" of a patient's condition at a specific moment. This capability is essential for healthcare professionals to assess and monitor patient health efficiently.

The rising incidence of chronic diseases such as cardiovascular diseases (CVDs), including heart failure, arrhythmias, coronary artery disease, respiratory diseases, diabetes, and neurology diseases are the significant driver for the spot monitors market. For instance, according to CDC data in October 2024, heart disease is indeed the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. All these factors demand the spot monitors market.

Market Dynamics: Drivers & Restraints

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases is significantly driving the growth of the spot monitor market and is expected to drive throughout the market forecast period.

The rise in lifestyle-related chronic conditions such as cardiovascular diseases, diabetes, and respiratory illnesses necessitates continuous and accurate monitoring of vital signs. This trend drives the demand for effective spot-monitoring solutions that provide timely data for better disease management.

According to WHO data in September 2023, NCDs are responsible for 41 million deaths annually, making them the leading cause of mortality globally. Each year, about 17 million people die from NCDs before reaching the age of 70. A staggering 86% of premature NCD deaths occur in low- and middle-income countries. 77% of all NCD deaths happen in these regions. All these factors demand the spot monitors market.

Furthermore, key players' strategies such as partnerships and collaborations would drive the cardiac rhythm management devices market growth. For instance, in June 2023, Royal Philips announced a partnership with BIOTRONIK, a prominent medical device company specializing in cardiovascular and endovascular diseases. This collaboration aims to expand the range of cardiovascular devices available for Philips' SymphonySuite customers, enhancing the offerings for outpatient care settings such as office-based labs (OBLs) and ambulatory surgery centers (ASCs).

Moreover, the growing aging population and technological advancements are the factors expected to drive the spot market over the forecast period.

High cost of devices

The initial investment required for advanced spot monitoring systems can be significant, encompassing not only the cost of the devices themselves but also additional expenses related to training staff and integrating these systems into existing healthcare infrastructures.

Advanced spot monitoring devices can be expensive, often costing thousands of dollars depending on their features and capabilities. For instance, sophisticated models that provide multiple vital sign measurements or integrate with telehealth systems may have higher price points.

For instance, Mindray's ePM 10A Patient Monitor is a vital sign monitoring device designed for healthcare settings. The monitor is listed with a sale price of $4,295.00- $4,695.00. The high cost of devices is expected to hinder spot monitor market growth.

Segment Analysis

The global spot monitor market is segmented based on product type, parameters monitored, application, end-user, distribution channel, and region.

Parameters Monitored :

Vital signs monitoring segment is expected to dominate the spot monitor market share

The vital signs monitoring segment holds a major portion of the spot monitor market share and is expected to continue to hold a significant portion of the spot monitor market share during the forecast period.

Vital signs monitoring are monitoring basic vital signs such as temperature, heart rate, oxygen saturation, and blood pressure. These measures are important for detecting abnormalities in the body. Due to technological advancements, these devices became lightweight, portable, and compact. It is ideal for adults, pediatrics, and even neonates.

Vital signs monitoring plays an important role in detecting diseases. An increase in chronic infections increases the demand and usage. For instance, according to the National Council on Aging, 2023, approximately 95% of adults 60 and older have at least one chronic condition, while more than 80% have two or more. Obesity alone impacts about 42% of adults 60 and older, leading to major conditions like cardiovascular diseases and hypertension, in which Americans hold the highest percentage.

Furthermore, key players in the industry product launches and approvals that would drive this segment growth in the market. For instance, in June 2023, Masimo got 510(K) clearances from the US Food and Drug Administration for its patient-worn, continuous multi-parameter vital signs monitor called Radius VSM. This product enables clinicians to monitor several physiological measurements such as Masimo SET pulse oximetry, temperature, respiration rate, and electrocardiography. These factors have solidified the segment's position in the spot monitor market.

Cardiac monitoring segment is the fastest-growing segment in the spot monitor market share

The cardiac monitoring segment is the fastest-growing segment in the spot monitor market share and is expected to hold the market share over the forecast period.

Cardiac monitoring assists in the continuous examination of a patient's cardiac electrical activity in the form of pressure waveforms. The activity of these devices depends on continuous and intermittent heart activity, usually through electrocardiography. These devices are typically used to diagnose heart aberrations and help in the treatment of serious cardiac disorders such as heart failure, and atrial fibrillation among others.

The rising prevalence of cardiovascular diseases (CVDs) is a significant driving factor for cardiac monitoring devices in the spot monitors market. This increase in cases of CVDs leads to a higher demand for effective monitoring and treatment solutions, directly impacting the growth and expansion of the cardiac monitoring devices market.

According to World Heart Federation data in April 2023, CVDs have been the leading cause of death globally. In 2021, 20.5 million people died from a cardiovascular condition, which accounted for around one-third of all global deaths and was a significant increase from the 12.1 million CVD deaths recorded in 1990. As more individuals are diagnosed with heart-related issues, healthcare providers require effective tools to monitor these patients continuously, leading to an uptick in the adoption of devices like pacemakers, defibrillators, and cardiac resynchronization therapy (CRT) systems.

Geographical Analysis

North America is expected to hold a significant position in the spot monitor market share

North America holds a substantial position in the food as medicine market and is expected to hold most of the market share. The increasing incidence of chronic conditions such as cardiovascular diseases, diabetes, and respiratory illnesses necessitates continuous monitoring of patients' vital signs.

Spot monitors provide healthcare professionals with timely data, enabling better disease management and patient outcomes. Innovations in medical technology, including portable and wireless monitoring devices, have made spot monitors more accessible and user-friendly. These advancements enhance the accuracy and reliability of vital sign measurements, driving their adoption in both clinical and home settings.

Furthermore, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, technological advancements, and product launches & approvals would propel the genital dysfunction drugs market growth. For instance, in April 2024, the FDA clearance of Corsano Health's CardioWatch System marks a significant advancement in remote patient monitoring (RPM) technology, particularly for European systems entering the U.S. market. This patient-friendly, real-time monitoring system is designed to enhance the user experience and address common challenges associated with existing RPM solutions.

Asia Pacific is growing at the fastest pace in the spot monitor market

The rising incidence of chronic conditions in the Asia Pacific region drives the spot monitor market. Spot monitors provide healthcare professionals with timely data that enhances disease management and improves patient outcomes. As technology continues to evolve, these devices will play an increasingly important role in managing chronic diseases effectively, ultimately contributing to better health outcomes for patients across the region.

Furthermore, key player's strategies such as partnerships & collaborations, and product launches would drive this spot market growth in the region. In January 2024, Medtronic announced a strategic partnership with Cardiac Design Labs (CDL) to launch and expand access to a novel heart rhythm monitoring technology called Padma Rhythms in India. This collaboration aims to enhance cardiac care by providing comprehensive, long-term heart monitoring through an External Loop Recorder (ELR) patch.

Also, in October 2023, MicroPort CRM announced the launch of the ULYS Implantable Cardioverter Defibrillator (ICD) and INVICTA defibrillation lead in Japan. This introduction highlights MicroPort's commitment to advancing cardiac care technology and expanding its product offerings in the global spot monitor market.

Competitive Landscape

The major global players in the spot monitor market include Koninklijke Philips N.V., Baxter International Inc., Masimo, Medtronic, GE HealthCare., Mindray DS USA, Inc., Nihon Kohden Corporation, OMRON Healthcare, Inc., ZOLL Medical Corporation, and Contec among others.

Emerging Players

The emerging players in the spot monitor market include HealthSnap, Inc., SmartCardia Inc., iRhythm Technologies, Inc., Turtle Shell Technologies Pvt Ltd, Athelas Incorporated., Accuhealth Technologies LLC, and Bionet among others.

Key Developments

  • In October 2023, Boston Scientific launched the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, a next-generation device designed for long-term monitoring of arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke, and syncope. This innovative system enhances the capabilities of cardiac monitoring and aims to improve patient care through advanced technology.

Why Purchase the Report?

  • To visualize the global spot monitor market segmentation based on product type, parameters monitored, application, end-user, distribution channel, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the spot monitor market with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in excel consisting of key products of all the major players.

The global spot monitor market report would provide approximately 78 tables, 80 figures, and 183 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Parameters Monitored
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Distribution Channels
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Standalone Spot Monitors *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Portable Spot Monitors
  • 6.4. Wearable Spot Monitors
  • 6.5. Integrated Spot Monitors (Monitors Integrated into Other Devices)

7. By Parameters Monitored

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Parameters Monitored
    • 7.1.2. Market Attractiveness Index, By Parameters Monitored
  • 7.2. Vital Signs Monitoring *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Heart Rate
    • 7.2.4. Blood Pressure
    • 7.2.5. Oxygen Saturation (SpO2)
    • 7.2.6. Temperature
    • 7.2.7. Respiratory Rate
  • 7.3. Cardiac Monitoring
    • 7.3.1. ECG
    • 7.3.2. Arrhythmia Detection
  • 7.4. Neurological Monitoring
    • 7.4.1. Brain Activity
    • 7.4.2. Intracranial Pressure Monitoring

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Hospital Settings*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Emergency Departments
  • 8.4. Intensive Care Units (ICUs)
  • 8.5. Operating Rooms
  • 8.6. Outpatient Care
  • 8.7. Home Healthcare
  • 8.8. Sports Medicine
  • 8.9. Industrial Settings

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Home Healthcare Providers
  • 9.5. Rehabilitation Centers
  • 9.6. Sports Facilities

10. By Distribution Channel

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.1.2. Market Attractiveness Index, By Distribution Channel
  • 10.2. Direct Sales *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Medical Equipment Distributors
  • 10.4. Online Sales

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Parameters Monitored
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Parameters Monitored
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Parameters Monitored
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Parameters Monitored
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Parameters Monitored
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Koninklijke Philips N.V. *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Baxter International Inc.
  • 13.3. Masimo
  • 13.4. Medtronic
  • 13.5. GE HealthCare.
  • 13.6. Mindray DS USA, Inc.
  • 13.7. Nihon Kohden Corporation
  • 13.8. OMRON Healthcare, Inc.
  • 13.9. ZOLL Medical Corporation
  • 13.10. Contec

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us